|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1613269447 |
003 |
DE-627 |
005 |
20230427172637.0 |
007 |
tu |
008 |
040830s2004 xx ||||| 00| ||eng c |
020 |
|
|
|a 9241209232
|9 92-4-120923-2
|
035 |
|
|
|a (DE-627)1613269447
|
035 |
|
|
|a (DE-576)113149867
|
035 |
|
|
|a (DE-599)BSZ113149867
|
035 |
|
|
|a (OCoLC)56349565
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Rheumatic fever and rheumatic heart disease
|b report of a WHO expert consultation, Geneva, 29 October - 1 November 2001
|
264 |
|
1 |
|a Geneva
|b World Health Organization
|c 2004
|
264 |
|
1 |
|a Geneva
|c 2004
|
300 |
|
|
|a VII, 122 S.
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
490 |
1 |
|
|a Technical report series / World Health Organization
|v 923
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
810 |
2 |
|
|a Weltgesundheitsorganisation
|t Technical report series / World Health Organization
|v 923
|9 923
|w (DE-627)129933295
|w (DE-576)01549067X
|w (DE-600)390033-2
|x 0512-3054
|7 ns
|
889 |
|
|
|w (DE-576)320609936
|
912 |
|
|
|a GBV_ILN_2024
|
912 |
|
|
|a ISIL_DE-B208
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
951 |
|
|
|a BO
|
980 |
|
|
|2 2024
|1 01
|x DE-B208
|b 3174302455
|c 00
|f --%%--
|d Int: X Publ: S1
|e p
|j --%%--
|y l01
|z 30-08-04
|